These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37954063)

  • 1. Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
    Postel MD; Darabi S; Howe JR; Liang WS; Craig DW; Demeure MJ
    F1000Res; 2023; 12():417. PubMed ID: 37954063
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
    de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
    Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
    Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
    J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
    Samsom KG; Levy S; van Veenendaal LM; Roepman P; Kodach LL; Steeghs N; Valk GD; Wouter Dercksen M; Kuhlmann KFD; Verbeek WHM; Meijer GA; Tesselaar MET; van den Berg JG
    Histopathology; 2021 Mar; 78(4):556-566. PubMed ID: 32931025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.
    Sei Y; Zhao X; Forbes J; Szymczak S; Li Q; Trivedi A; Voellinger M; Joy G; Feng J; Whatley M; Jones MS; Harper UL; Marx SJ; Venkatesan AM; Chandrasekharappa SC; Raffeld M; Quezado MM; Louie A; Chen CC; Lim RM; Agarwala R; Schäffer AA; Hughes MS; Bailey-Wilson JE; Wank SA
    Gastroenterology; 2015 Jul; 149(1):67-78. PubMed ID: 25865046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
    Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
    BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
    Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
    Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.
    Walter D; Harter PN; Battke F; Winkelmann R; Schneider M; Holzer K; Koch C; Bojunga J; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Waidmann O
    Sci Rep; 2018 Feb; 8(1):3811. PubMed ID: 29491456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
    Mäkinen N; Zhou M; Zhang Z; Kasai Y; Perez E; Kim GE; Thirlwell C; Nakakura E; Meyerson M
    Genome Med; 2022 Aug; 14(1):82. PubMed ID: 35922826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
    Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
    Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
    Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
    Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
    D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
    Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.
    Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
    Am J Pathol; 2001 May; 158(5):1803-8. PubMed ID: 11337378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
    Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
    Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.